CSL · 2 hours ago
Senior Manager US Advertising & Promotion Lead
CSL is a global biotherapeutics leader focused on innovation to improve patient outcomes. The Senior Manager US Advertising & Promotion Lead will ensure compliance with drug promotion regulations, review promotional materials, and provide regulatory guidance to support commercial success.
BiotechnologyHealth CareHealth DiagnosticsMedical
Responsibilities
Ensure compliance with HA drug promotion and promotional labeling regulations for assigned licensed products
Review, approve, or reject promotional programming based on U.S. Code of Federal Regulations and FDA implementing regulations and guidance
Adhere to related SOPs and work instructions for established MCC/PRC processes
Review advertising and promotional labeling; comment, improve, approve, or reject material based on company practice, CSL policy, U.S. law, and FDA regulations
Collaborate with Commercial Operations Marketing, Legal, and Medical personnel to minimize HA enforcement risk while supporting CSL’s commercial success
Monitor and apply trends in advertising and promotional labeling regulations to CSL U.S. regional review practices and processes
Provide regulatory leadership and guidance to marketing during development, review, and approval of promotional materials for assigned therapeutic areas
Prepare and submit advertising and promotional labeling materials to the FDA as required under 21 CFR 314.81(b)(3)(i) or 21 CFR 601.45
Maintain technical biologics/medical knowledge for assigned therapeutic areas
Actively contribute to the global CSL regulatory community through designated projects and assignments
Review and advise product development teams on communication strategies or tactics regarding investigational products
Qualification
Required
Bachelor's Degree Life Science
Minimum 3 years in Regulatory, Medical, or Legal Affairs or other relevant experience
Skilled in implementing regulatory science and monitoring enforcement trends
Ability to read and comprehend product-related technical and medical information
Company
CSL
CSL develops innovative biotherapies and influenza vaccines that save lives, and help people with life-threatening medical conditions.
Funding
Current Stage
Public CompanyTotal Funding
$111M2013-12-20Acquired
2004-02-06Post Ipo Equity· $111M
1994-06-03IPO
Recent News
2025-10-29
Sydney Morning Herald - Business
2025-10-28
Company data provided by crunchbase